With any new trend or shift in the labor and job landscape, it’s natural to be cautious of how it may affect you or your workers, both personally and professionally. Automation is here to help though, not hurt.
In this article, Aaron Green sits down with Darnell Smith, founder and CEO of MXXN, a cannabis beverage company commercializing cannabis infused non-alcoholic spirits. After a career in the spirits industry where he began to experiment with tinctures, Darnell launched his brand to bring the flavors of spirits to the cannabis industry.
As cannabis lounges continue to pop up across the U.S., it’s critical these businesses protect themselves and their bottom line, ensuring they’re covered from potential risks and accidents. It’s a classic risk-reward situation; while these bar-like establishments are expected to add nearly $100 million to the U.S. economy this year, there’s also the added risk of openly serving cannabis products to people who will have different experiences.
Recent statements by food safety agencies in the US and EU show that regulatory uncertainty for CBD infused edibles will continue for the foreseeable future.
In addition to their partnership with Agricor and Botanacor in Colorado that they announced, the recent hire of a new CEO and a new partnership in Michigan means the company is looking at expansion on a nationwide level.
Increasing yield or production output in a cannabis cultivation facility can often be as simple as having the right cultivation plan in place to ensure that you are harvesting the maximum number of times per year.
This is the story of Christopher Lacy and The TGC Group. Before he was old enough to drink, he went to prison for cannabis. Their story is one of misfortune, persistence, family and the dreadful effects that cannabis prohibition has had on impoverished BIPOC communities. His team recently won a conditional license under New Jersey’s social equity licensing program. Looking to the future, he hopes his business can be a force for good and that his story can inspire others to do the same.
We looked at 10 major pharmaceutical companies and 10 major cannabis companies, comparing what positions they had for scientists and their R&D spending. Why are scientists rarely in the c-suite of cannabis companies?
A Leafreport industry study allegedly found that only 7% of CBD brands, of the 188 brands sampled, actually conduct legitimate contamination testing for pesticides, heavy metals and microbial contamination.
The Center for Scientific Cannabinoid Information (CSCI) announced their launch on June 14, with the goal of cutting through the confusion around cannabinoids and providing resources for medical professionals for information on the safety and efficacy of cannabinoids.
